Skip to main content
. 2019 May 15;20(10):2413. doi: 10.3390/ijms20102413

Figure 1.

Figure 1

Cumulative incidence of grade II–IV acute graft-versus-host disease (GVHD) according to CYP3A5 genotype during the first four weeks following HSCT. Cumulative incidence is plotted from the day of stem cell transplantation (day 0), with curves for each genotypic variant.